About the Company
We do not have any company description for Insight Molecular Diagnostics Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc (IMDX) Q2 2025 Earnings Call Highlights: Strategic Advances ...
Insight Molecular Diagnostics Inc (IMDX) progresses towards FDA submission and product launch, despite facing revenue and ...
Insight Molecular Diagnostics Inc. (IMDX) Stock Price Today - WSJ
View the latest Insight Molecular Diagnostics Inc. (IMDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Insight Molecular Diagnostics Inc.: IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch
Reiterating timelines for FDA submission in 2025Transplant clinical trial has attracted leading transplant hospitalsBooked first revenue from first-generation GraftAssureIQ research-use-only kits; beg ...
Insight Molecular Diagnostics Inc.
View Insight Molecular Diagnostics Inc. IMDX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Insight Molecular Diagnostics Inc. (IMDX) - Yahoo Finance
Get the detailed quarterly/annual income statement for Insight Molecular Diagnostics Inc. (IMDX). Find out the revenue, expenses and profit or loss over the last fiscal year.
IMDX Insight Molecular Diagnostics Inc. - Seeking Alpha
Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K GlobeNewswireFri, Mar. 31, 2023 ...
Insight Molecular Diagnostics Inc IMDX - Morningstar
Check out our IMDX stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
Insight Molecular Diagnostics Inc Revenue - Investing.com
Insight Molecular Diagnostics's latest twelve months revenue is 3.843 million. View Insight Molecular Diagnostics Inc's (NASDAQCM:IMDX) Revenue trends, charts, and more.
Insight Molecular Diagnostics Inc. - MarketWatch
Insight Molecular Diagnostics Inc. Quarterly cash flow by MarketWatch. View IMDX net cash flow, operating cash flow, operating expenses and cash dividends.
Insight Molecular Diagnostics Inc Revenue - Investing.com UK
Insight Molecular Diagnostics's latest twelve months revenue is 3.843 million Insight Molecular Diagnostics's revenue for fiscal years ending December 2020 to 2024 averaged 1.551 million. Insight ...
Insight Molecular Diagnostics Inc IMDX - Morningstar
Review Insight Molecular Diagnostics Inc (IMDX:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
Similar Companies
Loading the latest forecasts...